{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T10:38:13Z","timestamp":1769942293417,"version":"3.49.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T00:00:00Z","timestamp":1331337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00726-011-1209-3","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T07:20:41Z","timestamp":1331277641000},"page":"129-142","source":"Crossref","is-referenced-by-count":22,"title":["\u03b3-Glutamylamines and neurodegenerative diseases"],"prefix":"10.1007","volume":"44","author":[{"given":"Thomas M.","family":"Jeitner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Battaile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur J. L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,10]]},"reference":[{"key":"1209_CR1","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1021\/bi00644a016","volume":"16","author":"T Abe","year":"1977","unstructured":"Abe T, Chung SI, DiAugustine RP, Folk JE (1977) Rabbit liver transglutaminase: physical, chemical and catalytic properties. Biochemistry 16:5495\u20135501","journal-title":"Biochemistry"},{"key":"1209_CR2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","volume":"431","author":"M Arrasate","year":"2004","unstructured":"Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431:805\u2013810","journal-title":"Nature"},{"key":"1209_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0021-9673(00)94804-0","volume":"443","author":"S Beninati","year":"1988","unstructured":"Beninati S, Martinet N, Folk JE (1988a) High-performance liquid chromatographic method for the determination of \u03b5-(\u03b3-glutamyl)lysine and mono- and bis-\u03b3-glutamyl derivatives of putrescine and spermidine. J Chromatogr 443:329\u2013335","journal-title":"J Chromatogr"},{"key":"1209_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0167-4838(88)90134-3","volume":"952","author":"S Beninati","year":"1988","unstructured":"Beninati S, Piacentini M, Cocuzzi ET, Autuori F, Folk JE (1988b) Covalent incorporation of polyamines as \u03b3-glutamyl derivatives into CHO cell protein. Biochim Biophys Acta 952:325\u2013333","journal-title":"Biochim Biophys Acta"},{"key":"1209_CR5","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M610893200","volume":"282","author":"M Bisaglia","year":"2007","unstructured":"Bisaglia M, Mammi S, Bubacco L (2007) Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with \u03b1-synuclein. J Biol Chem 282:15597\u201315605","journal-title":"J Biol Chem"},{"key":"1209_CR6","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbrc.2010.03.044","volume":"394","author":"M Bisaglia","year":"2010","unstructured":"Bisaglia M, Tosatto L, Munari F, Tessari I, de Laureto PP, Mammi S, Bubacco L (2010) Dopamine quinones interact with alpha-synuclein to form unstructured adducts. Biochem Biophys Res Commun 394:424\u2013428","journal-title":"Biochem Biophys Res Commun"},{"key":"1209_CR7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1517\/14728222.2010.510134","volume":"14","author":"D Caccamo","year":"2010","unstructured":"Caccamo D, Curro M, Ientile R (2010) Potential of transglutaminase 2 as a therapeutic target. Expert Opin Ther Targets 14:989\u20131003","journal-title":"Expert Opin Ther Targets"},{"key":"1209_CR8","unstructured":"Chen S-E (2008) Modeling, design, and development of potential inhibitors of \u03b3-glutamylamine cyclotransferase and inhibitors of cruzain as therapeutic agents for Chagas\u2019 disease Chemistry and Biochemistry Ph.D."},{"key":"1209_CR9","doi-asserted-by":"crossref","first-page":"8703","DOI":"10.1074\/jbc.275.12.8703","volume":"275","author":"YC Choi","year":"2000","unstructured":"Choi YC, Park GT, Kim TS, Sunwoo IN, Steinert PM, Kim SY (2000) Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2. J Biol Chem 275:8703\u20138710","journal-title":"J Biol Chem"},{"key":"1209_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.69.2.303","volume":"69","author":"SI Chung","year":"1972","unstructured":"Chung SI, Folk JE (1972) Transglutaminase from hair follicle of guinea pig (crosslinking-fibrin-glutamyllysine-isoenzymes-purified enzyme). Proc Natl Acad Sci USA 69:303\u2013307","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR11","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1074\/jbc.M004776200","volume":"276","author":"BA Citron","year":"2001","unstructured":"Citron BA, SantaCruz KS, Davies PJ, Festoff BW (2001) Intron\u2013exon swapping of transglutaminase mRNA and neuronal Tau aggregation in Alzheimer\u2019s disease. J Biol Chem 276:3295\u20133301","journal-title":"J Biol Chem"},{"key":"1209_CR12","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1152\/physrev.1987.67.2.440","volume":"67","author":"AJL Cooper","year":"1987","unstructured":"Cooper AJL, Plum F (1987) Biochemistry and physiology of brain ammonia. Physiol Rev 67:440\u2013519","journal-title":"Physiol Rev"},{"key":"1209_CR13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1046\/j.1471-4159.1997.69010431.x","volume":"69","author":"AJL Cooper","year":"1997","unstructured":"Cooper AJL, Sheu KF, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP (1997a) Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded CAG\/poly-Q neurodegenerative diseases? J Neurochem 69:431\u2013434","journal-title":"J Neurochem"},{"key":"1209_CR14","doi-asserted-by":"crossref","first-page":"12604","DOI":"10.1073\/pnas.94.23.12604","volume":"94","author":"AJL Cooper","year":"1997","unstructured":"Cooper AJL, Sheu KR, Burke JR, Onodera O, Strittmatter WJ, Roses AD, Blass JP (1997b) Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and \u03b1-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc Natl Acad Sci USA 94:12604\u201312609","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0197-0186(01)00058-4","volume":"40","author":"AJL Cooper","year":"2002","unstructured":"Cooper AJL, Jeitner TM, Gentile V, Blass JP (2002) Cross linking of polyglutamine domains catalyzed by tissue transglutaminase is greatly favored with pathological-length repeats: does transglutaminase activity play a role in (CAG)n\/Qn-expansion diseases? Neurochem Int 40:53\u201367","journal-title":"Neurochem Int"},{"key":"1209_CR16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1006\/abio.2002.5587","volume":"303","author":"JW Danson","year":"2002","unstructured":"Danson JW, Trawick ML, Cooper AJL (2002) Spectrophotometric assays for l-lysine \u03b1-oxidase and \u03b3-glutamylamine cyclotransferase. Anal Biochem 303:120\u2013130","journal-title":"Anal Biochem"},{"key":"1209_CR17","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1523\/JNEUROSCI.22-20-08942.2002","volume":"22","author":"A Dedeoglu","year":"2002","unstructured":"Dedeoglu A, Kubilus JK, Jeitner TM, Matson SA, Bogdanov M, Kowall NW, Matson WR, Cooper AJL, Ratan RR, Beal MF, Hersch SM, Ferrante RJ (2002) Therapeutic effects of cystamine in a murine model of Huntington\u2019s disease. J Neurosci 22:8942\u20138950","journal-title":"J Neurosci"},{"key":"1209_CR18","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00702-005-0448-4","volume":"113","author":"M Fasano","year":"2006","unstructured":"Fasano M, Bergamasco B, Lopiano L (2006) Is neuromelanin changed in Parkinson\u2019s disease? Investigations by magnetic spectroscopies. J Neural Transm 113:769\u2013774","journal-title":"J Neural Transm"},{"key":"1209_CR19","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","volume":"86","author":"BA Faucheux","year":"2003","unstructured":"Faucheux BA, Martin ME, Beaumont C, Hauw JJ, Agid Y, Hirsch EC (2003) Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson\u2019s disease. J Neurochem 86:1142\u20131148","journal-title":"J Neurochem"},{"key":"1209_CR20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.neurobiolaging.2005.02.015","volume":"27","author":"H Fedorow","year":"2006","unstructured":"Fedorow H, Halliday GM, Rickert CH, Gerlach M, Riederer P, Double KL (2006) Evidence for specific phases in the development of human neuromelanin. Neurobiol Aging 27:506\u2013512","journal-title":"Neurobiol Aging"},{"key":"1209_CR21","doi-asserted-by":"crossref","first-page":"13771","DOI":"10.1016\/S0021-9258(17)38792-6","volume":"260","author":"L F\u00e9s\u00fcs","year":"1985","unstructured":"F\u00e9s\u00fcs L, Szucs EF, Barrett KE, Metcalfe DD, Folk JE (1985) Activation of transglutaminase and production of protein-bound \u03b3-glutamylhistamine in stimulated mouse mast cells. J Biol Chem 260:13771\u201313778","journal-title":"J Biol Chem"},{"key":"1209_CR22","doi-asserted-by":"crossref","unstructured":"Fink ML, Folk JE (1981) \u03b3-Glutamylamine cyclotransferase. An enzyme involved in the catabolism of \u03b5-(\u03b3-glutamyl)lysine and other \u03b3-glutamylamines. Mol Cell Biochem 38(Spec No):59\u201367","DOI":"10.1007\/BF00235688"},{"key":"1209_CR23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0076-6879(83)94063-6","volume":"94","author":"ML Fink","year":"1983","unstructured":"Fink ML, Folk JE (1983) \u03b3-Glutamylamine cyclotransferase (rabbit kidney). Methods Enzymol 94:347\u2013351","journal-title":"Methods Enzymol"},{"key":"1209_CR24","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1073\/pnas.77.8.4564","volume":"77","author":"ML Fink","year":"1980","unstructured":"Fink ML, Chung SI, Folk JE (1980) \u03b3-Glutamylamine cyclotransferase: specificity toward epsilon-(L-gamma-glutamyl)-l-lysine and related compounds. Proc Natl Acad Sci USA 77:4564\u20134568","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR25","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1016\/S0021-9258(18)83426-3","volume":"244","author":"JE Folk","year":"1969","unstructured":"Folk JE (1969) Mechanism of action of guinea pig liver transglutaminase, VI. Order of substrate addition. J Biol Chem 244:3707\u20133713","journal-title":"J Biol Chem"},{"key":"1209_CR26","first-page":"1","volume":"54","author":"JE Folk","year":"1983","unstructured":"Folk JE (1983) Mechanism and basis for specificity of transglutaminase-catalyzed \u03b5-(\u03b3-glutamyl) lysine bond formation. Adv Enzymol Relat Areas Mol Biol 54:1\u201356","journal-title":"Adv Enzymol Relat Areas Mol Biol"},{"key":"1209_CR27","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0926-6593(66)90066-X","volume":"122","author":"JE Folk","year":"1966","unstructured":"Folk JE, Cole PW (1966) Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim Biophys Acta 122:244\u2013264","journal-title":"Biochim Biophys Acta"},{"key":"1209_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3233(08)60217-X","volume":"31","author":"JE Folk","year":"1977","unstructured":"Folk JE, Finlayson JS (1977) The \u03b5-(\u03b3-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 31:1\u2013133","journal-title":"Adv Protein Chem"},{"key":"1209_CR29","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1016\/S0021-9258(19)85760-5","volume":"255","author":"JE Folk","year":"1980","unstructured":"Folk JE, Park MH, Chung SI, Schrode J, Lester EP, Cooper HL (1980) Polyamines as physiological substrates for transglutaminases. J Biol Chem 255:3695\u20133700","journal-title":"J Biol Chem"},{"key":"1209_CR30","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1006\/abbi.1998.0592","volume":"352","author":"V Gentile","year":"1998","unstructured":"Gentile V, Sepe C, Calvani M, Melone MA, Cotrufo R, Cooper AJL, Blass JP, Peluso G (1998) Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases. Arch Biochem Biophys 352:314\u2013321","journal-title":"Arch Biochem Biophys"},{"key":"1209_CR31","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(92)90719-P","volume":"581","author":"WR Gibb","year":"1992","unstructured":"Gibb WR (1992) Melanin, tyrosine hydroxylase calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson\u2019s disease. Brain Res 581:283\u2013291","journal-title":"Brain Res"},{"key":"1209_CR32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(92)91334-B","volume":"593","author":"PF Good","year":"1992","unstructured":"Good PF, Olanow CW, Perl DP (1992) Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson\u2019s disease: a LAMMA study. Brain Res 593:343\u2013346","journal-title":"Brain Res"},{"key":"1209_CR33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0092-8674(93)90718-6","volume":"74","author":"H Green","year":"1993","unstructured":"Green H (1993) Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74:955\u2013956","journal-title":"Cell"},{"key":"1209_CR34","doi-asserted-by":"crossref","first-page":"33066","DOI":"10.1074\/jbc.M102553200","volume":"276","author":"P Grenard","year":"2001","unstructured":"Grenard P, Bates MK, Aeschlimann D (2001) Evolution of transglutaminase genes: identification of a transglutaminase gene cluster on human chromosome 15q15. Structure of the gene encoding transglutaminase X and a novel gene family member, transglutaminase. Z J Biol Chem 276:33066\u201333078","journal-title":"Z J Biol Chem"},{"key":"1209_CR35","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archneur.1993.00540110037003","volume":"50","author":"JF Gusella","year":"1993","unstructured":"Gusella JF, MacDonald ME, Ambrose CM, Duyao MP (1993) Molecular genetics of Huntington\u2019s disease. Arch Neurol 50:1157\u20131163","journal-title":"Arch Neurol"},{"key":"1209_CR36","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ana.21450","volume":"64","author":"M Hadjivassiliou","year":"2008","unstructured":"Hadjivassiliou M, Aeschlimann P, Strigun A, Sanders DS, Woodroofe N, Aeschlimann D (2008) Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol 64:332\u2013343","journal-title":"Ann Neurol"},{"key":"1209_CR37","doi-asserted-by":"crossref","first-page":"16790","DOI":"10.1074\/jbc.M802215200","volume":"283","author":"DM Hartley","year":"2008","unstructured":"Hartley DM, Zhao C, Speier AC, Woodard GA, Li S, Li Z, Walz T (2008) Transglutaminase induces protofibril-like amyloid beta-protein assemblies that are protease-resistant and inhibit long-term potentiation. J Biol Chem 283:16790\u201316800","journal-title":"J Biol Chem"},{"key":"1209_CR38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0006-291X(81)80194-5","volume":"102","author":"H Hennings","year":"1981","unstructured":"Hennings H, Steinert P, Buxman MM (1981) Calcium induction of transglutaminase and the formation of \u03b5(\u03b3-glutamyl) lysine cross-links in cultured mouse epidermal cells. Biochem Biophys Res Commun 102:739\u2013745","journal-title":"Biochem Biophys Res Commun"},{"key":"1209_CR39","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/humu.20952","volume":"30","author":"ML Herman","year":"2009","unstructured":"Herman ML, Farasat S, Steinbach PJ, Wei MH, Toure O, Fleckman P, Blake P, Bale SJ, Toro JR (2009) Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: summary of mutations (including 23 novel) and modeling of TGase-1. Hum Mutat 30:537\u2013547","journal-title":"Hum Mutat"},{"key":"1209_CR40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jms.1331","volume":"43","author":"G Hoffner","year":"2008","unstructured":"Hoffner G, Hoppilliard Y, van der Rest G, Dansette P, Djian P, Ohanessian G (2008) [N\u03b5-(\u03b3-glutamyl) lysine] as a potential biomarker in neurological diseases: new detection method and fragmentation pathways. J Mass Spectrom 43:456\u2013469","journal-title":"J Mass Spectrom"},{"key":"1209_CR41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ab.2008.09.039","volume":"384","author":"G Hoffner","year":"2009","unstructured":"Hoffner G, van der Rest G, Dansette PM, Djian P (2009) The end product of transglutaminase crosslinking: simultaneous quantitation of [N\u03b5-(\u03b3-glutamyl) lysine] and lysine by HPLC-MS3. Anal Biochem 384:296\u2013304","journal-title":"Anal Biochem"},{"key":"1209_CR42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/187152710791012107","volume":"9","author":"G Hoffner","year":"2010","unstructured":"Hoffner G, Andre W, Vanhoutteghem A, Soues S, Djian P (2010) Transglutaminase-catalyzed crosslinking in neurological disease: from experimental evidence to therapeutic inhibition CNS. Neurol Disord Drug Targets 9:217\u2013231","journal-title":"Neurol Disord Drug Targets"},{"key":"1209_CR43","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/hmg\/2.12.2069","volume":"2","author":"AT Hoogeveen","year":"1993","unstructured":"Hoogeveen AT, Willemsen R, Meyer N, de Rooij KE, Roos RA, van Ommen GJ, Galjaard H (1993) Characterization and localization of the Huntington disease gene product. Hum Mol Genet 2:2069\u20132073","journal-title":"Hum Mol Genet"},{"key":"1209_CR44","doi-asserted-by":"crossref","first-page":"12636","DOI":"10.1073\/pnas.1635052100","volume":"100","author":"SE Iismaa","year":"2003","unstructured":"Iismaa SE, Holman S, Wouters MA, Lorand L, Graham RM, Husain A (2003) Evolutionary specialization of a tryptophan indole group for transition-state stabilization by eukaryotic transglutaminases. Proc Natl Acad Sci USA 100:12636\u201312641","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR45","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1152\/physrev.00044.2008","volume":"89","author":"SE Iismaa","year":"2009","unstructured":"Iismaa SE, Mearns BM, Lorand L, Graham RM (2009) Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders. Physiol Rev 89:991\u20131023","journal-title":"Physiol Rev"},{"key":"1209_CR46","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1471-4159.2001.00673.x","volume":"79","author":"TM Jeitner","year":"2001","unstructured":"Jeitner TM, Bogdanov MB, Matson WR, Daikhin Y, Yudkoff M, Folk JE, Steinman L, Browne SE, Beal MF, Blass JP, Cooper AJL (2001) N\u03b5-(\u03b3-L-glutamyl)-l-lysine (GGEL) is increased in cerebrospinal fluid of patients with Huntington\u2019s disease. J Neurochem 79:1109\u20131112","journal-title":"J Neurochem"},{"key":"1209_CR47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1471-4159.2008.05350.x","volume":"106","author":"TM Jeitner","year":"2008","unstructured":"Jeitner TM, Matson WR, Folk JE, Blass JP, Cooper AJL (2008) Increased levels of \u03b3-glutamylamines in Huntington disease CSF. J Neurochem 106:37\u201344","journal-title":"J Neurochem"},{"key":"1209_CR48","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2217\/fnl.09.17","volume":"4","author":"TM Jeitner","year":"2009","unstructured":"Jeitner TM, Muma NA, Battaile KP, Cooper AJL (2009a) Transglutaminase activation in neurodegenerative diseases. Future Neurol 4:449\u2013467","journal-title":"Future Neurol"},{"issue":"Suppl 1","key":"1209_CR49","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1471-4159.2009.05843.x","volume":"109","author":"TM Jeitner","year":"2009","unstructured":"Jeitner TM, Pinto JT, Krasnikov BF, Horswill M, Cooper AJL (2009b) Transglutaminases and neurodegeneration. J Neurochem 109(Suppl 1):160\u2013166","journal-title":"J Neurochem"},{"key":"1209_CR50","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1471-4159.1992.tb08362.x","volume":"59","author":"K Jellinger","year":"1992","unstructured":"Jellinger K, Kienzl E, Rumpelmair G, Riederer P, Stachelberger H, Ben-Shachar D, Youdim MB (1992) Iron-melanin complex in substantia nigra of parkinsonian brains: an X-ray microanalysis. J Neurochem 59:1168\u20131171","journal-title":"J Neurochem"},{"key":"1209_CR51","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1073\/pnas.0438021100","volume":"100","author":"E Junn","year":"2003","unstructured":"Junn E, Ronchetti RD, Quezado MM, Kim SY, Mouradian MM (2003) Tissue transglutaminase-induced aggregation of \u03b1-synuclein: Implications for Lewy body formation in Parkinson\u2019s disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 100:2047\u20132052","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR52","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S1097-2765(00)80059-3","volume":"1","author":"P Kahlem","year":"1998","unstructured":"Kahlem P, Green H, Djian P (1998) Transglutaminase action imitates Huntington\u2019s disease: selective polymerization of Huntingtin containing expanded polyglutamine. Mol Cell 1:595\u2013601","journal-title":"Mol Cell"},{"key":"1209_CR53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","volume":"8","author":"MV Karpuj","year":"2002","unstructured":"Karpuj MV, Becher MW, Springer JE, Chabas D, Youssef S, Pedotti R, Mitchell D, Steinman L (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease with administration of the transglutaminase inhibitor cystamine. Nat Med 8:143\u2013149","journal-title":"Nat Med"},{"key":"1209_CR54","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1471-4159.1992.tb08350.x","volume":"59","author":"A Kastner","year":"1992","unstructured":"Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y (1992) Is the vulnerability of neurons in the substantia nigra of patients with Parkinson\u2019s disease related to their neuromelanin content? J Neurochem 59:1080\u20131089","journal-title":"J Neurochem"},{"key":"1209_CR55","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.274.43.30715","volume":"274","author":"SY Kim","year":"1999","unstructured":"Kim SY, Grant P, Lee JH, Pant HC, Steinert PM (1999) Differential expression of multiple transglutaminases in human brain. Increased expression and cross-linking by transglutaminases 1 and 2 in Alzheimer\u2019s disease. J Biol Chem 274:30715\u201330721","journal-title":"J Biol Chem"},{"key":"1209_CR56","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0197-0186(01)00064-X","volume":"40","author":"SY Kim","year":"2002","unstructured":"Kim SY, Jeitner TM, Steinert PM (2002) Transglutaminases in disease. Neurochem Int 40:85\u2013103","journal-title":"Neurochem Int"},{"key":"1209_CR57","doi-asserted-by":"crossref","first-page":"17520","DOI":"10.1074\/jbc.M413988200","volume":"280","author":"T Konno","year":"2005","unstructured":"Konno T, Morii T, Shimizu H, Oiki S, Ikura K (2005) Paradoxical inhibition of protein aggregation and precipitation by transglutaminase-catalyzed intermolecular cross-linking. J Biol Chem 280:17520\u201317525","journal-title":"J Biol Chem"},{"key":"1209_CR58","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/1531-8249(199912)46:6<842::AID-ANA6>3.0.CO;2-O","volume":"46","author":"S Kuemmerle","year":"1999","unstructured":"Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM, Ferrante RJ (1999) Huntington aggregates may not predict neuronal death in Huntington\u2019s disease. Ann Neurol 46:842\u2013849","journal-title":"Ann Neurol"},{"key":"1209_CR59","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1046\/j.1471-4159.2003.02249.x","volume":"88","author":"TS Lai","year":"2004","unstructured":"Lai TS, Tucker T, Burke JR, Strittmatter WJ, Greenberg CS (2004) Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats. J Neurochem 88:1253\u20131260","journal-title":"J Neurochem"},{"key":"1209_CR60","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1046\/j.1471-4159.1999.02018.x","volume":"73","author":"M Lesort","year":"1999","unstructured":"Lesort M, Chun W, Johnson GV, Ferrante RJ (1999) Tissue transglutaminase is increased in Huntington\u2019s disease brain. J Neurochem 73:2018\u20132027","journal-title":"J Neurochem"},{"key":"1209_CR61","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jnr.10217","volume":"68","author":"RM Liu","year":"2002","unstructured":"Liu RM (2002) Down-regulation of \u03b3-glutamylcysteine synthetase regulatory subunit gene expression in rat brain tissue during aging. J Neurosci Res 68:344\u2013351","journal-title":"J Neurosci Res"},{"key":"1209_CR62","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuroscience.2008.06.033","volume":"155","author":"P Liu","year":"2008","unstructured":"Liu P, Gupta N, Jing Y, Zhang H (2008) Age-related changes in polyamines in memory-associated brain structures in rats. Neuroscience 155:789\u2013796","journal-title":"Neuroscience"},{"key":"1209_CR63","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0925-4439(99)00116-7","volume":"1500","author":"L Lopiano","year":"2000","unstructured":"Lopiano L, Chiesa M, Digilio G, Giraudo S, Bergamasco B, Torre E, Fasano M (2000) Q-band EPR investigations of neuromelanin in control and Parkinson\u2019s disease patients. Biochim Biophys Acta 1500:306\u2013312","journal-title":"Biochim Biophys Acta"},{"key":"1209_CR64","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrm1014","volume":"4","author":"L Lorand","year":"2003","unstructured":"Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Natl Rev Mol Cell Biol 4:140\u2013156","journal-title":"Natl Rev Mol Cell Biol"},{"key":"1209_CR65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/bj2710305","volume":"271","author":"N Martinet","year":"1990","unstructured":"Martinet N, Beninati S, Nigra TP, Folk JE (1990) N1N8-bis(\u03b3-glutamyl)spermidine cross-linking in epidermal-cell envelopes. Comparison of cross-link levels in normal and psoriatic cell envelopes. Biochem J 271:305\u2013308","journal-title":"Biochem J"},{"key":"1209_CR66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cdd.4401093","volume":"9","author":"PG Mastroberardino","year":"2002","unstructured":"Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, Moreno S, Pavone F, Oliverio S, F\u00e9s\u00fcs L, Piacentini M (2002) \u2018Tissue\u2019 transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington\u2019s disease. Cell Death Differ 9:873\u2013880","journal-title":"Cell Death Differ"},{"key":"1209_CR67","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S0907444911007281","volume":"67","author":"S McNicholas","year":"2011","unstructured":"McNicholas S, Potterton E, Wilson KS, Noble ME (2011) Presenting your structures: the CCP4\u00a0mg molecular-graphics software Acta Crystallogr D. Biol Crystallogr 67:386\u2013394","journal-title":"Biol Crystallogr"},{"key":"1209_CR68","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0076-6879(85)13055-7","volume":"113","author":"A Meister","year":"1985","unstructured":"Meister A (1985) \u03b3-Glutamylcyclotransferase from rat kidney. Methods Enzymol 113:438\u2013445","journal-title":"Methods Enzymol"},{"key":"1209_CR69","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","volume":"4","author":"O Molberg","year":"1998","unstructured":"Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713\u2013717","journal-title":"Nat Med"},{"key":"1209_CR70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.1976.tb04444.x","volume":"26","author":"T Nakajima","year":"1976","unstructured":"Nakajima T, Kakimoto Y, Tsuji M, Konishi H (1976) Occurrence and formation of \u03b3-glutamylputrescine in mammalian brain. J Neurochem 26:115\u2013118","journal-title":"J Neurochem"},{"key":"1209_CR71","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.M608207200","volume":"282","author":"M Necula","year":"2007","unstructured":"Necula M, Kayed R, Milton S, Glabe CG (2007) Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem 282:10311\u201310324","journal-title":"J Biol Chem"},{"key":"1209_CR72","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1073\/pnas.96.15.8402","volume":"96","author":"Z Nemes","year":"1999","unstructured":"Nemes Z, Marekov LN, F\u00e9s\u00fcs L, Steinert PM (1999) A novel function for transglutaminase 1: attachment of long-chain omega-hydroxyceramides to involucrin by ester bond formation. Proc Natl Acad Sci USA 96:8402\u20138407","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1096\/fj.04-1493fje","volume":"18","author":"Z Nemes","year":"2004","unstructured":"Nemes Z, Devreese B, Steinert PM, Van Beeumen J, F\u00e9s\u00fcs L (2004) Cross-linking of ubiquitin, HSP27, parkin and \u03b1-synuclein by \u03b3-glutamyl-\u03b5-lysine bonds in Alzheimer\u2019s neurofibrillary tangles. FASEB J 18:1135\u20131137","journal-title":"FASEB J"},{"key":"1209_CR74","doi-asserted-by":"crossref","first-page":"27252","DOI":"10.1074\/jbc.M109.033969","volume":"284","author":"Z Nemes","year":"2009","unstructured":"Nemes Z, Petrovski G, Aerts M, Sergeant K, Devreese B, F\u00e9s\u00fcs L (2009) Transglutaminase-mediated intramolecular cross-linking of membrane-bound \u03b1-synuclein promotes amyloid formation in Lewy bodies. J Biol Chem 284:27252\u201327264","journal-title":"J Biol Chem"},{"key":"1209_CR75","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1074\/jbc.M109.082099","volume":"285","author":"AJ Oakley","year":"2010","unstructured":"Oakley AJ, Coggan M, Board PG (2010) Identification and characterization of \u03b3-glutamylamine cyclotransferase, an enzyme responsible for \u03b3-glutamyl-\u03b5-lysine catabolism. J Biol Chem 285:9642\u20139648","journal-title":"J Biol Chem"},{"key":"1209_CR76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1471-4159.2011.07187.x","volume":"117","author":"K Ono","year":"2011","unstructured":"Ono K, Yamada M (2011) Low-n oligomers as therapeutic targets of Alzheimer\u2019s disease. J Neurochem 117:19\u201328","journal-title":"J Neurochem"},{"key":"1209_CR77","doi-asserted-by":"crossref","first-page":"10311","DOI":"10.1074\/jbc.272.15.10311","volume":"272","author":"KN Parameswaran","year":"1997","unstructured":"Parameswaran KN, Cheng XF, Chen EC, Velasco PT, Wilson JH, Lorand L (1997) Hydrolysis of \u03b3:\u03b5 isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J Biol Chem 272:10311\u201310317","journal-title":"J Biol Chem"},{"key":"1209_CR78","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/BF03401886","volume":"1","author":"MF Perutz","year":"1995","unstructured":"Perutz MF (1995) Glutamine repeats as polar zippers: their role in inherited neurodegenerative disease. Mol Med 1:718\u2013721","journal-title":"Mol Med"},{"key":"1209_CR79","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jmb.2009.02.007","volume":"387","author":"CL Pham","year":"2009","unstructured":"Pham CL, Leong SL, Ali FE, Kenche VB, Hill AF, Gras SL, Barnham KJ, Cappai R (2009) Dopamine and the dopamine oxidation product 5, 6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. J Mol Biol 387:771\u2013785","journal-title":"J Mol Biol"},{"key":"1209_CR80","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1016\/S0021-9258(18)68993-8","volume":"263","author":"M Piacentini","year":"1988","unstructured":"Piacentini M, Martinet N, Beninati S, Folk JE (1988) Free and protein-conjugated polyamines in mouse epidermal cells. Effect of high calcium and retinoic acid. J Biol Chem 263:3790\u20133794","journal-title":"J Biol Chem"},{"key":"1209_CR81","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1371\/journal.pbio.0050327","volume":"5","author":"DM Pinkas","year":"2007","unstructured":"Pinkas DM, Strop P, Brunger AT, Khosla C (2007) Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol 5:e327","journal-title":"PLoS Biol"},{"key":"1209_CR82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.4331\/wjbc.v1.i5.181","volume":"1","author":"M Ricotta","year":"2010","unstructured":"Ricotta M, Iannuzzi M, Vivo GD, Gentile V (2010) Physio-pathological roles of transglutaminase-catalyzed reactions. World J Biol Chem 1:181\u2013187","journal-title":"World J Biol Chem"},{"key":"1209_CR83","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/hmg\/2.10.1713","volume":"2","author":"DC Rubinsztein","year":"1993","unstructured":"Rubinsztein DC, Barton DE, Davison BC, Ferguson-Smith MA (1993) Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington\u2019s disease and CAG repeat number. Hum Mol Genet 2:1713\u20131715","journal-title":"Hum Mol Genet"},{"key":"1209_CR84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1110\/ps.0216103","volume":"12","author":"M Ruoppolo","year":"2003","unstructured":"Ruoppolo M, Orru S, Francese S, Caputo I, Esposito C (2003) Structural characterization of transglutaminase-catalyzed cross-linking between glyceraldehyde 3-phosphate dehydrogenase and polyglutamine repeats. Protein Sci 12:170\u2013179","journal-title":"Protein Sci"},{"key":"1209_CR85","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0092-8674(00)81782-1","volume":"95","author":"F Saudou","year":"1998","unstructured":"Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55\u201366","journal-title":"Cell"},{"key":"1209_CR86","doi-asserted-by":"crossref","first-page":"13128","DOI":"10.1074\/jbc.M809067200","volume":"284","author":"AW Schmid","year":"2009","unstructured":"Schmid AW, Chiappe D, Pignat V, Grimminger V, Hang I, Moniatte M, Lashuel HA (2009) Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease. J Biol Chem 284:13128\u201313142","journal-title":"J Biol Chem"},{"key":"1209_CR87","doi-asserted-by":"crossref","first-page":"12172","DOI":"10.1074\/jbc.M110.176149","volume":"286","author":"AW Schmid","year":"2011","unstructured":"Schmid AW, Condemi E, Tuchscherer G, Chiappe D, Mutter M, Vogel H, Moniatte M, Tsybin YO (2011) Tissue transglutaminase-mediated glutamine deamidation of beta-amyloid peptide increases peptide solubility, whereas enzymatic cross-linking and peptide fragmentation may serve as molecular triggers for rapid peptide aggregation. J Biol Chem 286:12172\u201312188","journal-title":"J Biol Chem"},{"key":"1209_CR88","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:NEON.0000021804.50002.85","volume":"67","author":"MH Schmidt","year":"2004","unstructured":"Schmidt MH, Meyer GA, Reichert KW, Cheng J, Krouwer HG, Ozker K, Whelan HT (2004) Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors. J Neurooncol 67:201\u2013207","journal-title":"J Neurooncol"},{"key":"1209_CR89","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1110\/ps.036103.108","volume":"17","author":"IM Segers-Nolten","year":"2008","unstructured":"Segers-Nolten IM, Wilhelmus MM, Veldhuis G, van Rooijen BD, Drukarch B, Subramaniam V (2008) Tissue transglutaminase modulates \u03b1-synuclein oligomerization. Protein Sci 17:1395\u20131402","journal-title":"Protein Sci"},{"key":"1209_CR90","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1073\/pnas.79.19.6070","volume":"79","author":"DJ Selkoe","year":"1982","unstructured":"Selkoe DJ, Abraham C, Ihara Y (1982) Brain transglutaminase: in vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc Natl Acad Sci USA 79:6070\u20136074","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR91","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1107\/S1744309110033658","volume":"66","author":"P Serrano","year":"2010","unstructured":"Serrano P, Pedrini B, Geralt M, Jaudzems K, Mohanty B, Horst R, Herrmann T, Elsliger MA, Wilson IA, Wuthrich K (2010) Comparison of NMR and crystal structures highlights conformational isomerism in protein active sites. Acta Crystallogr Sect F Struct Biol Cryst Commun 66:1393\u20131405","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"1209_CR92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0197-0186(01)00061-4","volume":"40","author":"SM Singer","year":"2002","unstructured":"Singer SM, Zainelli GM, Norlund MA, Lee JM, Muma NA (2002) Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer\u2019s disease. Neurochem Int 40:17\u201330","journal-title":"Neurochem Int"},{"key":"1209_CR93","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.bbapap.2008.08.011","volume":"1784","author":"J Stamnaes","year":"2008","unstructured":"Stamnaes J, Fleckenstein B, Sollid LM (2008) The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim Biophys Acta 1784:1804\u20131811","journal-title":"Biochim Biophys Acta"},{"key":"1209_CR94","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0076-6879(85)13053-3","volume":"113","author":"SS Tate","year":"1985","unstructured":"Tate SS, Meister A (1985) \u03b3-Glutamyl transpeptidase from kidney. Methods Enzymol 113:400\u2013419","journal-title":"Methods Enzymol"},{"key":"1209_CR95","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.4049\/jimmunol.161.4.1585","volume":"161","author":"Y Wal van de","year":"1998","unstructured":"van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G, Koning F (1998) Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161:1585\u20131588","journal-title":"J Immunol"},{"key":"1209_CR96","doi-asserted-by":"crossref","unstructured":"Verhaar R, Jongenelen CA, Gerard M, Baekelandt V, Van Dam AM, Wilhelmus MM, Drukarch B (2011) Blockade of enzyme activity inhibits tissue transglutaminase-mediated transamidation of \u03b1-synuclein in a cellular model of Parkinson\u2019s disease. Neurochem Int 58:785\u2013793","DOI":"10.1016\/j.neuint.2011.03.004"},{"key":"1209_CR97","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejphar.2008.01.059","volume":"585","author":"MM Wilhelmus","year":"2008","unstructured":"Wilhelmus MM, van Dam AM, Drukarch B (2008) Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases. Eur J Pharmacol 585:464\u2013472","journal-title":"Eur J Pharmacol"},{"key":"1209_CR98","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1750-3639.2008.00197.x","volume":"19","author":"MM Wilhelmus","year":"2009","unstructured":"Wilhelmus MM, Grunberg SC, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, Drukarch B (2009) Transglutaminases and transglutaminase-catalyzed cross-links colocalize with the pathological lesions in Alzheimer\u2019s disease brain. Brain Pathol 19:612\u2013622","journal-title":"Brain Pathol"},{"key":"1209_CR99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1750-3639.2010.00429.x","volume":"21","author":"MM Wilhelmus","year":"2011","unstructured":"Wilhelmus MM, Verhaar R, Andringa G, Bol JG, Cras P, Shan L, Hoozemans JJ, Drukarch B (2011a) Presence of tissue transglutaminase in granular endoplasmic reticulum is characteristic of melanized neurons in Parkinson\u2019s disease brain. Brain Pathol 21:130\u2013139","journal-title":"Brain Pathol"},{"key":"1209_CR100","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.neurobiolaging.2009.04.019","volume":"32","author":"MM Wilhelmus","year":"2011","unstructured":"Wilhelmus MM, Verhaar R, Bol JG, van Dam AM, Hoozemans JJ, Rozemuller AJ, Drukarch B (2011b) Novel role of transglutaminase 1 in corpora amylacea formation? Neurobiol Aging 32:845\u2013856","journal-title":"Neurobiol Aging"},{"key":"1209_CR101","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/path.2984","volume":"226","author":"MM Wilhelmus","year":"2012","unstructured":"Wilhelmus MM, de Jager M, Rozemuller AJ, Breve J, Bol JG, Eckert RL, Drukarch B (2012) Transglutaminase 1 and its regulator tazarotene-induced gene 3 localize to neuronal tau inclusions in tauopathies. J Pathol 226:132\u2013142","journal-title":"J Pathol"},{"key":"1209_CR102","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnen\/62.1.14","volume":"62","author":"GM Zainelli","year":"2003","unstructured":"Zainelli GM, Ross CA, Troncoso JC, Muma NA (2003) Transglutaminase cross-links in intranuclear inclusions in Huntington disease. J Neuropathol Exp Neurol 62:14\u201324","journal-title":"J Neuropathol Exp Neurol"},{"key":"1209_CR103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/jnen\/64.1.58","volume":"64","author":"GM Zainelli","year":"2005","unstructured":"Zainelli GM, Dudek NL, Ross CA, Kim SY, Muma NA (2005) Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3. J Neuropathol Exp Neurol 64:58\u201365","journal-title":"J Neuropathol Exp Neurol"},{"key":"1209_CR104","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0306-4522(96)00047-4","volume":"73","author":"L Zecca","year":"1996","unstructured":"Zecca L, Shima T, Stroppolo A, Goj C, Battiston GA, Gerbasi R, Sarna T, Swartz HM (1996) Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience 73:407\u2013415","journal-title":"Neuroscience"},{"key":"1209_CR105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0014-5793(01)03269-0","volume":"510","author":"L Zecca","year":"2002","unstructured":"Zecca L, Fariello R, Riederer P, Sulzer D, Gatti A, Tampellini D (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method increases throughout the life and is dramatically decreased in Parkinson\u2019s disease. FEBS Lett 510:216\u2013220","journal-title":"FEBS Lett"},{"key":"1209_CR106","doi-asserted-by":"crossref","first-page":"17567","DOI":"10.1073\/pnas.0808768105","volume":"105","author":"L Zecca","year":"2008","unstructured":"Zecca L, Bellei C, Costi P, Albertini A, Monzani E, Casella L, Gallorini M, Bergamaschi L, Moscatelli A, Turro NJ, Eisner M, Crippa PR, Ito S, Wakamatsu K, Bush WD, Ward WC, Simon JD, Zucca FA (2008) New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals. Proc Natl Acad Sci USA 105:17567\u201317572","journal-title":"Proc Natl Acad Sci USA"},{"key":"1209_CR107","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jnen\/59.11.983","volume":"59","author":"MO Zemaitaitis","year":"2000","unstructured":"Zemaitaitis MO, Lee JM, Troncoso JC, Muma NA (2000) Transglutaminase-induced cross-linking of tau proteins in progressive supranuclear palsy. J Neuropathol Exp Neurol 59:983\u2013989","journal-title":"J Neuropathol Exp Neurol"},{"key":"1209_CR108","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s004010050910","volume":"96","author":"W Zhang","year":"1998","unstructured":"Zhang W, Johnson BR, Suri DE, Martinez J, Bjornsson TD (1998) Immunohistochemical demonstration of tissue transglutaminase in amyloid plaques. Acta Neuropathol 96:395\u2013400","journal-title":"Acta Neuropathol"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-011-1209-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-011-1209-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-011-1209-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T07:32:31Z","timestamp":1713684751000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-011-1209-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,10]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["1209"],"URL":"https:\/\/doi.org\/10.1007\/s00726-011-1209-3","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,10]]}}}